Ironwood Pharmaceuticals is trading 5.4% higher at $4.30, with no clear catalyst identified for the move.

  • This reverses the August 13, 2026 close of $4.08.
  • No new company-specific announcement or credible report directly explaining the August 14, 2026 move was identified.
  • The broader market is modestly lower; recent company news remains centered on August 6 second-quarter results and raised 2026 guidance.